These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5682096)
41. [Effect of low-molecular-weight dextran (40,000) on the levels of inorganic phosphorus and lipid-bound phosphorus in the blood of patients with a transient disorder of cerebral circulation]. Kawiak W; Pilarczyk M; Jarosz M; Gieracz-Nazar A Wiad Lek; 1987 Aug; 40(16):1088-93. PubMed ID: 2449766 [No Abstract] [Full Text] [Related]
42. [Preliminary observations on the corticosteroid treatment of acute myocardial infarct]. Calzavara G; Lusiani GB Cardiol Prat; 1967 Feb; 18(1):27-38. PubMed ID: 5600975 [No Abstract] [Full Text] [Related]
43. [Experience in the treatment of acute myocardial infarct with streptokinase]. LuchivianskiÄ M; Shpaniar E; Markukiak I; Radakovich M Ter Arkh; 1975; 47(7):51-4. PubMed ID: 1224350 [No Abstract] [Full Text] [Related]
45. [Digitalis in acute myocardial infarct]. Hochrein H; Beck OA; Wolf R Med Welt; 1974 Apr; 25(16):693-8. PubMed ID: 4832388 [No Abstract] [Full Text] [Related]
46. [Thrombolytic treatment with streptokinase in acute myocardial infarct]. Binaghi G; Repetto S; Mortarino G; Ferrari GP; Ambrosetti P Minerva Med; 1980 Apr; 71(16):1201-2. PubMed ID: 7375041 [No Abstract] [Full Text] [Related]
47. [The use of naniprus in patients with myocardial infarct complicated by acute left ventricular failure]. MalinovskiÄ IaV Lik Sprava; 1993 Jan; (1):89-91. PubMed ID: 8379148 [TBL] [Abstract][Full Text] [Related]
48. [First clinical experiences with high doses of adrenal steroids in the treatment of acute myocardial infarct]. Kraska T; Zochowski RJ; Korewicki J; Opolski G Kardiol Pol; 1978; 21(4):293-9. PubMed ID: 691938 [No Abstract] [Full Text] [Related]
49. [Prenylamine in cardiology, especially at the acute phase of myocardial infarct]. Witchitz S; Bonnet M; Chiche P Coeur Med Interne; 1969 Jul; 8(3):409-15. PubMed ID: 5398961 [No Abstract] [Full Text] [Related]
50. Effect of dextran 40,000 on the contents of inorganic phosphorus and phospholipids in the blood of patients with cerebral infarction at the very beginning of illness. Kawiak W; Pilarczyk M; Gieracz-Nazar A Mater Med Pol; 1988; 20(2):95-7. PubMed ID: 2464725 [No Abstract] [Full Text] [Related]
51. [Dextran of low molecular weight in peripheral arterial insufficiency]. Amoroso A; Guadagno L; Pozzi LL Omnia Med Ther; 1965; 43(1):151-67. PubMed ID: 5824979 [No Abstract] [Full Text] [Related]
53. [The results of using pyridoxilate (glio-6) during the acute period of a myocardial infarct and in patients with pre-infarct state]. Gal'sman ML Kardiologiia; 1972 Dec; 12(12):108. PubMed ID: 4661907 [No Abstract] [Full Text] [Related]
54. The treatment of atherosclerotic peripheral arterial insufficiency with low molecular weight dextran intravenously. Lewis SR; Johnson JB J Natl Med Assoc; 1966 Jul; 58(4):261-4. PubMed ID: 5947681 [No Abstract] [Full Text] [Related]
57. [Clinical use of a low molecular weight dextran]. Larcan A; Calamai M; Genetet B Therapie; 1965; 20(5):1265-79. PubMed ID: 5850105 [No Abstract] [Full Text] [Related]
58. [Possibility of erroneous evaluation of diabetes compensation during treatment with low-molecular dextran]. Eisner M; Grabowska MJ; Dobrohorska H; Nowotko U Pol Tyg Lek; 1971 Dec; 26(51):1982-4. PubMed ID: 5139578 [No Abstract] [Full Text] [Related]